# Medefer

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medefer

- Industry: Healthcare IT
- Headquarters: London, UK
- Website: www.medefer.com
- Total disclosed funding: $13M
- Latest round: Series A (Sep 14, 2020)
- Investors on record: 2

## About

Medefer Limited provides innovative private healthcare solutions, focusing on efficient access to a range of medical services for patients, including treatments for weight loss, skin issues, and cancer testing.Medefer Limited, founded in 2013, is headquartered in London, UK. The company offers a remote self-referral system that connects patients with consultant-led care. Bahman Nedjat-Shokouhi is both the CEO and founder. In September 2020, Medefer raised GBP 10 million in Series A funding led by Nickleby Capital. This funding round represents the total amount raised by the company, which has successfully completed 2 deals.Medefer specializes in providing private healthcare solutions that streamline access to medical services for patients, focusing on treatments including weight loss, skin problems, menopause support, prostate cancer testing, and sleep issues. The company offers an innovative remote self-referral system, enabling patients to connect with award-winning consultant-led care without long waiting lists. Medefer primarily operates within the UK market, ensuring patients have access to high-quality healthcare services regardless of their geographical location.Medefer generates revenue through a direct-to-consumer model, where patients pay for individual treatments rather than subscribing to a service. Each service is priced according to its specific nature, fostering flexibility in healthcare access. As a registered pharmacy with General Medical Council (GMC) accredited doctors, Medefer maintains high standards of care while facilitating a seamless payment process for timely consultations and medical interventions.In September 2020, Medefer Limited raised GBP 10 million in Series A funding, which will support its strategic initiatives for future growth. The company aims to enhance its service offerings and is exploring the introduction of new products designed to meet diverse patient needs. Additionally, Medefer plans to expand into new geographic regions, targeting areas within the UK and potentially other European markets by 2022.

## Funding rounds

- Series A, Sep 14, 2020, $13M — Nickleby Capital
- Seed, Jun 2, 2015, $0.2M — Seedcamp

## Investors

- Seedcamp (https://capitalatlas.ai/funds/seedcamp) — Seed
- Nickleby Capital (https://capitalatlas.ai/funds/nickleby-capital) — Series A